Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
112,960,810
-
Share change
-
-173,832
-
Total reported value
-
$16,459,439,315
-
Put/Call ratio
-
62%
-
Price per share
-
$145.85
-
Number of holders
-
397
-
Value change
-
-$76,904,527
-
Number of buys
-
175
-
Number of sells
-
211
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q2 2022
As of 30 Jun 2022,
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) was held by
397 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
112,960,810 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, Capital World Investors, BAILLIE GIFFORD & CO, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, Dodge & Cox, STATE STREET CORP, and JPMORGAN CHASE & CO.
This page lists
403
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.